PANADOL EXTRA Trademark

Trademark Overview

On Tuesday, October 18, 2016, a trademark application was filed for PANADOL EXTRA with the United States Patent and Trademark Office. The USPTO has given the PANADOL EXTRA trademark a serial number of 87207338. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, January 10, 2024. This trademark is owned by GlaxoSmithKline Consumer Healthcare (UK) IP Limited. The PANADOL EXTRA trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic preparations
panadol extra

General Information

Serial Number87207338
Word MarkPANADOL EXTRA
Filing DateTuesday, October 18, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, January 10, 2024
Registration Number5520257
Registration DateTuesday, July 17, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Goods and ServicesAnalgesic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 21, 2016
Primary Code005
First Use Anywhere DateSunday, April 30, 2017
First Use In Commerce DateSunday, April 30, 2017

Trademark Owner History

Party NameHALEON UK IP LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWEYBRIDGE, SURREY KT13 0NY
Party NameGlaxoSmithKline Consumer Healthcare (UK)IP Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxoSmithKline Consumer Healthcare (UK)IP Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiddlesex, TW8 9GS
GB
Party NameGlaxoSmithKline Consumer Healthcare (UK) IP Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiddlesex, TW8 9GS

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 10, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, January 10, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 10, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 17, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, July 17, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 25, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 13, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, April 13, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 28, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 17, 2018REGISTERED-PRINCIPAL REGISTER
Friday, June 15, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 14, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 21, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, April 30, 2018USE AMENDMENT FILED
Monday, May 21, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 30, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, November 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 31, 2017SOU EXTENSION 1 GRANTED
Tuesday, October 31, 2017SOU EXTENSION 1 FILED
Tuesday, October 31, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 26, 2017ASSIGNED TO EXAMINER
Friday, October 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 21, 2016NEW APPLICATION ENTERED

Related Keywords

extra panadol preparations analgesic